[["primary_diagnosis.program_id",{"left":{"name":"program_id","valueType":"string","description":"Unique identifier of the ARGO program.","restrictions":{"required":true}},"diff":{"type":"deleted","data":{"name":"program_id","valueType":"string","description":"Unique identifier of the ARGO program.","restrictions":{"required":true}}}}],["primary_diagnosis.submitter_donor_id",{"left":{"name":"submitter_donor_id","valueType":"string","description":"Unique identifier of the donor, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"},"meta":{"core":true}},"right":{"name":"submitter_donor_id","valueType":"string","description":"Unique identifier of the donor, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"}},"diff":{"meta":{"type":"deleted","data":{"core":true}}}}],["primary_diagnosis.age_at_diagnosis",{"left":{"name":"age_at_diagnosis","valueType":"integer","description":"Age that the donor was first diagnosed with cancer, in years.","restrictions":{"required":true},"meta":{"units":"years","core":true}},"right":{"name":"age_at_diagnosis","valueType":"integer","description":"Age that the donor was first diagnosed with cancer, in years.","restrictions":{"required":true,"range":{"min":0,"max":200}},"meta":{"units":"years"}},"diff":{"restrictions":{"range":{"type":"created","data":{"min":0,"max":200}}},"meta":{"core":{"type":"deleted","data":true}}}}],["primary_diagnosis.cancer_type_code",{"left":{"name":"cancer_type_code","valueType":"string","description":"The code to represent the cancer type using the WHO ICD-10 code (https://icd.who.int/browse10/2016/en#/) classification.","restrictions":{"required":true,"regex":"[A-Z]{1}[0-9]{2}.[0-9]{0,3}[A-Z]{0,1}$"},"meta":{"core":true}},"right":{"name":"cancer_type_code","valueType":"string","description":"The code to represent the cancer type using the WHO ICD-10 code (https://icd.who.int/browse10/2016/en#/) classification.","restrictions":{"required":true,"regex":"[A-Z]{1}[0-9]{2}.[0-9]{0,3}[A-Z]{1}$"}},"diff":{"restrictions":{"regex":{"type":"updated","data":"[A-Z]{1}[0-9]{2}.[0-9]{0,3}[A-Z]{1}$"}},"meta":{"type":"deleted","data":{"core":true}}}}],["primary_diagnosis.number_lymph_nodes_positive",{"left":{"name":"number_lymph_nodes_positive","description":"The number of regional lymph nodes reported as being positive for tumour metastases","valueType":"integer","restrictions":{"required":true},"meta":{"core":true}},"diff":{"type":"deleted","data":{"name":"number_lymph_nodes_positive","description":"The number of regional lymph nodes reported as being positive for tumour metastases","valueType":"integer","restrictions":{"required":true},"meta":{"core":true}}}}],["primary_diagnosis.clinical_tumour_staging_system",{"left":{"name":"clinical_tumour_staging_system","valueType":"string","description":"Specify the tumour staging system used to stage the cancer at the time of primary diagnosis (prior to treatment).","restrictions":{"required":true,"codeList":["Binet","Rai","FIGO","Ann Arbor","Murphy","Lugano","AJCC 8th Edition","AJCC 7th Edition","AJCC 6th Edition","AJCC 5th Edition","AJCC 4th Edition","AJCC 3rd Edition","AJCC 2nd Edition","AJCC 1st Edition"]},"meta":{"core":true}},"diff":{"type":"deleted","data":{"name":"clinical_tumour_staging_system","valueType":"string","description":"Specify the tumour staging system used to stage the cancer at the time of primary diagnosis (prior to treatment).","restrictions":{"required":true,"codeList":["Binet","Rai","FIGO","Ann Arbor","Murphy","Lugano","AJCC 8th Edition","AJCC 7th Edition","AJCC 6th Edition","AJCC 5th Edition","AJCC 4th Edition","AJCC 3rd Edition","AJCC 2nd Edition","AJCC 1st Edition"]},"meta":{"core":true}}}}],["primary_diagnosis.clinical_stage_group",{"left":{"name":"clinical_stage_group","description":"Stage group of the tumour, as assigned by the reporting tumour_staging_system, that indicates the overall prognostic tumour stage (ie. Stage I, Stage II, Stage III etc.).","valueType":"string","restrictions":{"script":"validateWithMagic(depends on tumour_staging_system selected value)"},"meta":{"core":true}},"right":{"name":"clinical_stage_group","description":"Stage group of the tumour, as assigned by the reporting tumour_staging_system, that indicates the overall prognostic tumour stage (ie. Stage I, Stage II, Stage III etc.).","valueType":"string"},"diff":{"restrictions":{"type":"deleted","data":{"script":"validateWithMagic(depends on tumour_staging_system selected value)"}},"meta":{"type":"deleted","data":{"core":true}}}}],["primary_diagnosis.stage_suffix",{"left":{"name":"stage_suffix","description":"If necessary, use this field to add any applicable stage suffixes. Stage suffixes may apply to certain staging systems such as Ann Arbour staging system where the four stages are divided into 4 categories (A, B, X and E).","valueType":"string","restrictions":{"script":"validateWithMagic(depends on tumour_staging_system selected value)","codeList":["Stage 0","Stage IA","Stage IIA","Stage IB","Stage IIB","Stage III","Stage IV"]},"meta":{"core":true}},"right":{"name":"stage_suffix","description":"If necessary, use this field to add any applicable stage suffixes. Stage suffixes may apply to certain staging systems such as Ann Arbour staging system where the four stages are divided into 4 categories (A, B, X and E).","valueType":"string"},"diff":{"restrictions":{"type":"deleted","data":{"script":"validateWithMagic(depends on tumour_staging_system selected value)","codeList":["Stage 0","Stage IA","Stage IIA","Stage IB","Stage IIB","Stage III","Stage IV"]}},"meta":{"type":"deleted","data":{"core":true}}}}],["primary_diagnosis.clinical_t_category",{"left":{"name":"clinical_t_category","description":"The code to represent the extent of the primary tumour (T) based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string","restrictions":{"script":"validateWithMagic(only needed if tumour_staging_system=AJCC)"},"meta":{"core":true}},"right":{"name":"clinical_t_category","description":"The code to represent the extent of the primary tumour (T) based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string"},"diff":{"restrictions":{"type":"deleted","data":{"script":"validateWithMagic(only needed if tumour_staging_system=AJCC)"}},"meta":{"type":"deleted","data":{"core":true}}}}],["primary_diagnosis.clinical_n_category",{"left":{"name":"clinical_n_category","description":"The code to represent the stage of cancer defined by which is the extent of the regional lymph node (N) involvement for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string","restrictions":{"script":"clinicaWithMagic(only needed if tumour_staging_system=AJCC)"},"meta":{"core":true}},"right":{"name":"clinical_n_category","description":"The code to represent the stage of cancer defined by which is the extent of the regional lymph node (N) involvement for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string"},"diff":{"restrictions":{"type":"deleted","data":{"script":"clinicaWithMagic(only needed if tumour_staging_system=AJCC)"}},"meta":{"type":"deleted","data":{"core":true}}}}],["primary_diagnosis.clinical_m_category",{"left":{"name":"clinical_m_category","description":"The code to represent the stage of cancer defined bythe extent of the distant metastasis (M) for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual. MX is NOT a valid category and cannot be assigned.","valueType":"string","restrictions":{"script":"validateWithMagic(only needed if tumour_staging_system=AJCC)"},"meta":{"core":true}},"right":{"name":"clinical_m_category","description":"The code to represent the stage of cancer defined bythe extent of the distant metastasis (M) for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual. MX is NOT a valid category and cannot be assigned.","valueType":"string"},"diff":{"restrictions":{"type":"deleted","data":{"script":"validateWithMagic(only needed if tumour_staging_system=AJCC)"}},"meta":{"type":"deleted","data":{"core":true}}}}],["primary_diagnosis.performance_status",{"left":{"name":"performance_status","description":"Indicate the patient's performance status at the time of primary diagnosis (ECOG performance score https://ecog-acrin.org/resources/ecog-performance-status).","valueType":"string","restrictions":{"codeList":["Fully active, able to carry on all pre-disease performance without restriction","Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (ie. Light house work, office work)","Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours","Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours","Completely disabled; cannot carry on any selfcare; totally confined to bed or chair"]}},"diff":{"type":"deleted","data":{"name":"performance_status","description":"Indicate the patient's performance status at the time of primary diagnosis (ECOG performance score https://ecog-acrin.org/resources/ecog-performance-status).","valueType":"string","restrictions":{"codeList":["Fully active, able to carry on all pre-disease performance without restriction","Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (ie. Light house work, office work)","Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours","Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours","Completely disabled; cannot carry on any selfcare; totally confined to bed or chair"]}}}}],["primary_diagnosis.tumour_staging_system",{"right":{"name":"tumour_staging_system","valueType":"string","description":"Specify the tumour staging system used to stage the cancer at the time of primary diagnosis (prior to treatment).","restrictions":{"required":true,"codeList":["Binet","Rai","FIGO","Ann Arbor","Murphy","Lugano","AJCC 8th Edition","AJCC 7th Edition","AJCC 6th Edition","AJCC 5th Edition","AJCC 4th Edition","AJCC 3rd Edition","AJCC 2nd Edition","AJCC 1st Edition"]}},"diff":{"type":"created","data":{"name":"tumour_staging_system","valueType":"string","description":"Specify the tumour staging system used to stage the cancer at the time of primary diagnosis (prior to treatment).","restrictions":{"required":true,"codeList":["Binet","Rai","FIGO","Ann Arbor","Murphy","Lugano","AJCC 8th Edition","AJCC 7th Edition","AJCC 6th Edition","AJCC 5th Edition","AJCC 4th Edition","AJCC 3rd Edition","AJCC 2nd Edition","AJCC 1st Edition"]}}}}],["primary_diagnosis.menopause_status",{"right":{"name":"menopause_status","description":"Indicate the menopause status of the patient at the time of primary diagnosis.","valueType":"string","restrictions":{"codeList":["Perimenopausal","Postmenopausal","Premenopausal","Unknown"]}},"diff":{"type":"created","data":{"name":"menopause_status","description":"Indicate the menopause status of the patient at the time of primary diagnosis.","valueType":"string","restrictions":{"codeList":["Perimenopausal","Postmenopausal","Premenopausal","Unknown"]}}}}]]